Tao Synergies Inc (TAOX)

$3.81 -0.25 (-6.16%)
Market Cap 30.34M
Revenue (ttm) 300,000.00
Net Income (ttm) -28.74M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -9,580.00%
Debt to Equity Ratio 0.00
Volume 177,800
Avg Vol 178,206
Day's Range N/A - N/A
Shares Out 7.47M
Stochastic %K 21%
Beta 1.41
Analysts Strong Buy
Price Target N/A

Company Profile

TAO Synergies Inc. owns and operates an AI token. The company executes a cryptocurrency treasury strategy centered on the acquisition and staking of the TAO token, the native utility token of the Bittensor network. TAO Synergies Inc. was formerly known as Synaptogenix, Inc. and changed its name to TAO Synergies Inc. in June 2025. The company was incorporated in 2012 and is headquartered in New York, New York.

Industry: Software - Infrastructure
Sector: Technology
Phone: 973 242 0005
Address:
1185 Avenue of the Americas, 3rd Floor, New York, United States
lordofthesox
lordofthesox Jun. 5 at 5:03 PM
$TAOX This may be a controversial opinion, but here I go: Holding speculative assets while paying a management team to do basically nothing isn't really a business.
2 · Reply
bobtheunbuilder
bobtheunbuilder Jun. 5 at 3:22 PM
$TAOX can we go back to being a biotec?
0 · Reply
EndGame1
EndGame1 Jun. 4 at 5:20 PM
$SOFI My top 5 horses… SoFi $DGXX $TAOX $OPEN and FABC.
0 · Reply
EndGame1
EndGame1 Jun. 4 at 5:00 PM
$TAOX Finally some life. BTC crash gave us this gift. Hoping the company picked up more cheap $TAO.X
0 · Reply
JohnnyP5
JohnnyP5 Jun. 3 at 1:55 PM
$TAOX picked up 400 more shares today at $3.94. I’m hoping these will be back above $6 by the end August. 🤞
0 · Reply
SnoopyPotter
SnoopyPotter Jun. 3 at 12:54 PM
$TAOX JAy Altucher speaking at Proof of Talk at the Louvre, Paris France https://x.com/taodaily_io/status/2061838895751286958?s=20
0 · Reply
EndGame1
EndGame1 Jun. 2 at 8:21 PM
$TAOX $BTC.X is killing the sector. "Bittensor Drops 7.8% Amid Broad AI Sector Sell-Off: Bittensor's price fell 7.8% in 24 hours, dropping from $256.31 to $233.38, impacting its market cap by $190 million. Despite ongoing developments and conference presence, the broader AI token market experienced a downturn."
0 · Reply
SnoopyPotter
SnoopyPotter Jun. 2 at 7:20 PM
$TAOX The photo is from today’s (June 2, 2026) Proof of Talk by xVentures panel in Paris titled “Subnets as an Asset Class: Building the On-Ramps for Institutional Capital.” James Altucher was a key speaker with Frank Schuil (Safello), Evan Malanga (Yuma), Siam Kidd (DSV Fund), and moderator Victor Teixeira. Recent good news: As TAOX’s Digital Assets Advisor, Altucher’s high-profile appearance highlights growing institutional interest in Bittensor subnets. He also spoke at Google’s 2025 “Planet Scale Consumer AI” event on decentralized AI capturing the $300B–$30T AI boom, positioning TAOX as a major beneficiary. TAOX raised $11M (backed by Altucher and DCG) to acquire more TAO, strengthening its status as the top public pure-play DeAI vehicle.
1 · Reply
EndGame1
EndGame1 Jun. 2 at 2:10 PM
$TAOX Even though price crashed, a lot happening... "Bittensor Subnet 28 Live, TAO Becomes Gas for Private Inference Source 1 source about 1 hour Bittensor (TAO) Bridges to Solana via Wormhole Source 1 source about 2 hours Bittensor Subnet Ecosystem Accelerates with Growing Institutional Interest Source 2 sources about 2 hours Bittensor (TAO) Completes First Token Halving, Reducing Emissions Source 2 sources about 10 hours Bittensor (TAO) Gains Retail Momentum from High-Profile Crypto Accounts SourceSource 5 sources about 10 hours Bittensor (TAO) On-Chain Ownership Decentralization Strengthens"
0 · Reply
EndGame1
EndGame1 Jun. 2 at 1:57 PM
$TAOX I added another 1000 shares. Lowered my average nicely. Will be $10 by end of year. Real progress on subnets daily.
1 · Reply
Latest News on TAOX
Options Trading Now Available on Tradr's BEX, CSEX, NNEX & SNPXcsex

Nov 18, 2025, 5:15 PM EST - 7 months ago

Options Trading Now Available on Tradr's BEX, CSEX, NNEX & SNPXcsex

BEX CSEX NNEX SNPX

TAO Synergies and Yuma Asset Management to Host Livestream on X: Bittensor (TAO) and DeAI Innovation

Nov 18, 2025, 9:15 AM EST - 7 months ago

TAO Synergies and Yuma Asset Management to Host Livestream on X: Bittensor (TAO) and DeAI Innovation

Tradr Launches Leveraged ETFs on Bloom Energy, Celestica, NANO Nuclear & Synopsys

Nov 13, 2025, 6:46 AM EST - 7 months ago

Tradr Launches Leveraged ETFs on Bloom Energy, Celestica, NANO Nuclear & Synopsys

BEX CSEX NNEX SNPX

TAO Synergies files to sell 22.3M shares of common stock for holders

2025-11-12T21:22:16.000Z - 7 months ago

TAO Synergies files to sell 22.3M shares of common stock for holders

Tradr Set to Debut ETFs Targeting Bloom Energy, Celestica, Nano Nuclear and Synopsys

Nov 11, 2025, 11:26 AM EST - 7 months ago

Tradr Set to Debut ETFs Targeting Bloom Energy, Celestica, Nano Nuclear and Synopsys

BEX CSEX NNEX SNPX

TAO Synergies announces initial $750K investment in Bittensor Subnet Funds

2025-11-04T14:20:39.000Z - 7 months ago

TAO Synergies announces initial $750K investment in Bittensor Subnet Funds

TAO Synergies Announces Initial $750,000 Investment in Yuma Asset Management's Subnet Funds

Nov 4, 2025, 9:15 AM EST - 7 months ago

TAO Synergies Announces Initial $750,000 Investment in Yuma Asset Management's Subnet Funds

TAO Synergies reports total TAO increased to 54,058 tokens

2025-10-20T13:20:22.000Z - 8 months ago

TAO Synergies reports total TAO increased to 54,058 tokens

TAO Synergies Raises Bittensor (TAO) Holdings to over 54,000 Tokens, Largest Publicly Traded Holder of Top Decentralized AI Cryptocurrency

Oct 20, 2025, 9:15 AM EDT - 8 months ago

TAO Synergies Raises Bittensor (TAO) Holdings to over 54,000 Tokens, Largest Publicly Traded Holder of Top Decentralized AI Cryptocurrency

TAO Synergies announces $11M private placement

2025-10-13T21:15:14.000Z - 8 months ago

TAO Synergies announces $11M private placement

TAO Synergies Announces $11 Million Private Placement

Oct 13, 2025, 5:09 PM EDT - 8 months ago

TAO Synergies Announces $11 Million Private Placement

TAO Synergies Launches "The TAO Daily," the Premier Media Platform for All Things Bittensor (TAO)

Sep 22, 2025, 9:15 AM EDT - 9 months ago

TAO Synergies Launches "The TAO Daily," the Premier Media Platform for All Things Bittensor (TAO)

TAO Synergies Digital Assets Advisor James Altucher Speaks at Google's Planet Scale Consumer AI Event

Sep 8, 2025, 9:15 AM EDT - 9 months ago

TAO Synergies Digital Assets Advisor James Altucher Speaks at Google's Planet Scale Consumer AI Event

TAO Synergies Welcomes Top Bittensor (TAO) Leader as Advisor for AI-Focused Crypto Treasury Strategy

Aug 26, 2025, 9:15 AM EDT - 10 months ago

TAO Synergies Welcomes Top Bittensor (TAO) Leader as Advisor for AI-Focused Crypto Treasury Strategy

TAO Synergies files $100M mixed securities shelf

2025-08-14T20:55:13.000Z - 10 months ago

TAO Synergies files $100M mixed securities shelf

TAO Synergies acquires $10M of Bittensor

2025-07-17T13:21:08.000Z - 11 months ago

TAO Synergies acquires $10M of Bittensor

TAO Synergies files to sell 5.04M shares of common stock for holders

2025-07-11T21:05:08.000Z - 11 months ago

TAO Synergies files to sell 5.04M shares of common stock for holders

TAO Synergies (Formerly Synaptogenix) Begins Trading Under New Nasdaq Stock Symbol "TAOX" Effective at Market Open Today

Jul 1, 2025, 9:15 AM EDT - 1 year ago

TAO Synergies (Formerly Synaptogenix) Begins Trading Under New Nasdaq Stock Symbol "TAOX" Effective at Market Open Today

Synaptogenix Announces Name Change to TAO Synergies and New Ticker Symbol "TAOX" for Alignment with AI-Focused Crypto Treasury Strategy

Jun 26, 2025, 9:15 AM EDT - 1 year ago

Synaptogenix Announces Name Change to TAO Synergies and New Ticker Symbol "TAOX" for Alignment with AI-Focused Crypto Treasury Strategy

Synaptogenix Announces Initial TAO Acquisition under Crypto Treasury Strategy, Appoints BitGo as Custodian, and Commences Yield Generation Through Staking

Jun 24, 2025, 9:15 AM EDT - 1 year ago

Synaptogenix Announces Initial TAO Acquisition under Crypto Treasury Strategy, Appoints BitGo as Custodian, and Commences Yield Generation Through Staking

Synaptogenix Appoints Crypto Expert to Lead Digital Asset Treasury Strategy Focused Exclusively on Top-Valued AI Token

Jun 9, 2025, 9:00 AM EDT - 1 year ago

Synaptogenix Appoints Crypto Expert to Lead Digital Asset Treasury Strategy Focused Exclusively on Top-Valued AI Token

Synaptogenix Board of Directors Forms Special Committee to Explore Value Creation Opportunities Utilizing Balance Sheet Strength

Dec 20, 2024, 9:15 AM EST - 1 year ago

Synaptogenix Board of Directors Forms Special Committee to Explore Value Creation Opportunities Utilizing Balance Sheet Strength

Synaptogenix Announces $5.0 Million Financing

Sep 11, 2024, 9:00 AM EDT - 1 year ago

Synaptogenix Announces $5.0 Million Financing

Synaptogenix Announces New Collaboration with LSU Health New Orleans for Study of Proprietary Analogs in Spinal Cord Injury

Jul 18, 2024, 9:00 AM EDT - 2 years ago

Synaptogenix Announces New Collaboration with LSU Health New Orleans for Study of Proprietary Analogs in Spinal Cord Injury

Synaptogenix Announces FDA Authorization of IND Application for Clinical Trial for Bryostatin-1 in Multiple Sclerosis

Jun 26, 2024, 9:00 AM EDT - 2 years ago

Synaptogenix Announces FDA Authorization of IND Application for Clinical Trial for Bryostatin-1 in Multiple Sclerosis

Synaptogenix Applauds DEA Proposal to Reclassify Cannabis and Shares Expected Benefits to Cannasoul for Cannabinoid-Based Drug Discovery

May 7, 2024, 9:00 AM EDT - 2 years ago

Synaptogenix Applauds DEA Proposal to Reclassify Cannabis and Shares Expected Benefits to Cannasoul for Cannabinoid-Based Drug Discovery

Synaptogenix Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing

Apr 24, 2024, 9:15 AM EDT - 2 years ago

Synaptogenix Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing

Synaptogenix Announces Reverse Stock Split to Maintain Nasdaq Listing

Apr 3, 2024, 8:00 AM EDT - 2 years ago

Synaptogenix Announces Reverse Stock Split to Maintain Nasdaq Listing

Synaptogenix President Daniel L. Alkon, M.D.

Dec 19, 2023, 9:00 AM EST - 2 years ago

Synaptogenix President Daniel L. Alkon, M.D.

Synaptogenix Joins Leading Neuroscientists and Academics as Speaker at USC-Sponsored Forum on Age-Related Diseases including Alzheimer's

Dec 6, 2023, 9:00 AM EST - 2 years ago

Synaptogenix Joins Leading Neuroscientists and Academics as Speaker at USC-Sponsored Forum on Age-Related Diseases including Alzheimer's

Synaptogenix Acquires Significant Stake in Cannasoul Analtyics Ltd. Co-founded by The Technion - Israel Institute of Technology

Nov 2, 2023, 9:00 AM EDT - 2 years ago

Synaptogenix Acquires Significant Stake in Cannasoul Analtyics Ltd. Co-founded by The Technion - Israel Institute of Technology

Synaptogenix Announces Peer-Reviewed Publication of NIH-Sponsored Phase 2 Clinical Trial Results Demonstrating Safe, Significant, and Persistent Benefits of Bryostatin-1 in Advanced Alzheimer's Disease

Sep 26, 2023, 9:00 AM EDT - 2 years ago

Synaptogenix Announces Peer-Reviewed Publication of NIH-Sponsored Phase 2 Clinical Trial Results Demonstrating Safe, Significant, and Persistent Benefits of Bryostatin-1 in Advanced Alzheimer's Disease

Bryostatin-1 from Synaptogenix Shows Statistically Significant Results as an ALS Treatment in Pre-Clinical Independent Study

Sep 7, 2023, 9:00 AM EDT - 2 years ago

Bryostatin-1 from Synaptogenix Shows Statistically Significant Results as an ALS Treatment in Pre-Clinical Independent Study

Synaptogenix and Cleveland Clinic to Submit Investigational New Drug (IND) Application to FDA for Clinical Trial of Bryostatin-1 in Multiple Sclerosis

Jul 19, 2023, 9:00 AM EDT - 3 years ago

Synaptogenix and Cleveland Clinic to Submit Investigational New Drug (IND) Application to FDA for Clinical Trial of Bryostatin-1 in Multiple Sclerosis

Synaptogenix Abstract Highlighting Bryostatin-1 Benefits in Severe Alzheimer's Disease Accepted for Presentation at 11th International Brain Research Organization World Congress of Neuroscience

Jul 13, 2023, 9:00 AM EDT - 3 years ago

Synaptogenix Abstract Highlighting Bryostatin-1 Benefits in Severe Alzheimer's Disease Accepted for Presentation at 11th International Brain Research Organization World Congress of Neuroscience

Synaptogenix Provides Corporate Update and Outlines Potential Business Opportunities

Mar 7, 2023, 9:00 AM EST - 3 years ago

Synaptogenix Provides Corporate Update and Outlines Potential Business Opportunities

Synaptogenix Announces Topline Results from NIH-Sponsored Phase 2 Clinical Trial of Bryostatin-1 for Advanced Alzheimer's Disease

Dec 16, 2022, 9:00 AM EST - 3 years ago

Synaptogenix Announces Topline Results from NIH-Sponsored Phase 2 Clinical Trial of Bryostatin-1 for Advanced Alzheimer's Disease

Synaptogenix Announces $15 Million Private Placement with Existing Investors

Nov 18, 2022, 9:00 AM EST - 3 years ago

Synaptogenix Announces $15 Million Private Placement with Existing Investors

Synaptogenix to Present at ThinkEquity Investor Conference on October 26, 2022

Oct 19, 2022, 9:00 AM EDT - 3 years ago

Synaptogenix to Present at ThinkEquity Investor Conference on October 26, 2022

Synaptogenix Welcomes Lecanemab Phase 3 Trial Results

Sep 28, 2022, 11:50 AM EDT - 4 years ago

Synaptogenix Welcomes Lecanemab Phase 3 Trial Results

Synaptogenix Announces Live Appearance of its President and CSO on Streaming Financial News Network

Aug 12, 2022, 9:00 AM EDT - 4 years ago

Synaptogenix Announces Live Appearance of its President and CSO on Streaming Financial News Network

Synaptogenix Announces Changes to Scientific Advisory Board in Preparation for Phase 2 Data

Jul 26, 2022, 9:15 AM EDT - 4 years ago

Synaptogenix Announces Changes to Scientific Advisory Board in Preparation for Phase 2 Data

Synaptogenix Announces Corporate Update Conference Call

Jul 21, 2022, 9:15 AM EDT - 4 years ago

Synaptogenix Announces Corporate Update Conference Call

Synaptogenix Advances Dosing of First Patient in Dose Optimization Clinical Trial in Preparation for NIH-Sponsored, Phase 2 Alzheimer's Disease Trial Data

Jul 20, 2022, 9:15 AM EDT - 4 years ago

Synaptogenix Advances Dosing of First Patient in Dose Optimization Clinical Trial in Preparation for NIH-Sponsored, Phase 2 Alzheimer's Disease Trial Data

Synaptogenix to Present at the Cell Symposium

May 17, 2022, 9:15 AM EDT - 4 years ago

Synaptogenix to Present at the Cell Symposium

Synaptogenix Completes Patient Enrollment in NIH Sponsored Phase 2b Alzheimer's Disease Trial

Apr 19, 2022, 9:15 AM EDT - 4 years ago

Synaptogenix Completes Patient Enrollment in NIH Sponsored Phase 2b Alzheimer's Disease Trial

New Peer Reviewed Article Demonstrates Extended Therapeutic Potential of Synaptogenix's Bryostatin for Alzheimer's Disease

Apr 5, 2022, 9:15 AM EDT - 4 years ago

New Peer Reviewed Article Demonstrates Extended Therapeutic Potential of Synaptogenix's Bryostatin for Alzheimer's Disease

Synaptogenix to Present at Hanson Wade 10th Annual Neurodegenerative Drug Development Summit

Mar 29, 2022, 9:15 AM EDT - 4 years ago

Synaptogenix to Present at Hanson Wade 10th Annual Neurodegenerative Drug Development Summit

Synaptogenix to Present at Sachs 5th Annual Neuroscience Innovation Forum

Mar 22, 2022, 9:15 AM EDT - 4 years ago

Synaptogenix to Present at Sachs 5th Annual Neuroscience Innovation Forum

Synaptogenix to Present Research Highlighting Potential Broad Applicability for Lead Compound Bryostatin at the International Conference on Alzheimer's and Parkinson's Diseases (AD/PD 2022)

Mar 15, 2022, 9:15 AM EDT - 4 years ago

Synaptogenix to Present Research Highlighting Potential Broad Applicability for Lead Compound Bryostatin at the International Conference on Alzheimer's and Parkinson's Diseases (AD/PD 2022)

Synaptogenix Moves Forward with Clinical Development Plans for Bryostatin-1 as a Treatment for Multiple Sclerosis

Feb 23, 2022, 9:15 AM EST - 4 years ago

Synaptogenix Moves Forward with Clinical Development Plans for Bryostatin-1 as a Treatment for Multiple Sclerosis

Synaptogenix Announces Publication of Peer-Reviewed Scientific Article Evidencing Byrostatin-1's Improved Cognition Over Baseline in Advanced Alzheimer's Disease Patients

Feb 1, 2022, 9:15 AM EST - 4 years ago

Synaptogenix Announces Publication of Peer-Reviewed Scientific Article Evidencing Byrostatin-1's Improved Cognition Over Baseline in Advanced Alzheimer's Disease Patients

Synaptogenix Announces Participation at the H.C. Wainwright 23rd Annual Global Investment Conference

Sep 10, 2021, 9:00 AM EDT - 5 years ago

Synaptogenix Announces Participation at the H.C. Wainwright 23rd Annual Global Investment Conference

Synaptogenix Signs Memorandum Of Understanding with Nemours A.I. DuPont Hospital to Initiate Trial Using Bryostatin, Under Orphan Drug Status, to Treat Fragile X Syndrome

Aug 5, 2021, 10:00 AM EDT - 5 years ago

Synaptogenix Signs Memorandum Of Understanding with Nemours A.I. DuPont Hospital to Initiate Trial Using Bryostatin, Under Orphan Drug Status, to Treat Fragile X Syndrome

Synaptogenix Discloses Positive Results of Further Bryostatin Trial Analyses in Presentation at Alzheimer's Association International Conference 2021

Jul 26, 2021, 9:15 AM EDT - 5 years ago

Synaptogenix Discloses Positive Results of Further Bryostatin Trial Analyses in Presentation at Alzheimer's Association International Conference 2021

Synaptogenix Announces Conference Call to Discuss AAIC Abstract Findings

Jul 21, 2021, 9:00 AM EDT - 5 years ago

Synaptogenix Announces Conference Call to Discuss AAIC Abstract Findings

Synaptogenix to Present Data at Alzheimer's Association International Conference 2021 Highlighting Bryostatin Restores Cognitive Function Above Baseline

Jul 14, 2021, 9:00 AM EDT - 5 years ago

Synaptogenix to Present Data at Alzheimer's Association International Conference 2021 Highlighting Bryostatin Restores Cognitive Function Above Baseline

lordofthesox
lordofthesox Jun. 5 at 5:03 PM
$TAOX This may be a controversial opinion, but here I go: Holding speculative assets while paying a management team to do basically nothing isn't really a business.
2 · Reply
bobtheunbuilder
bobtheunbuilder Jun. 5 at 3:22 PM
$TAOX can we go back to being a biotec?
0 · Reply
EndGame1
EndGame1 Jun. 4 at 5:20 PM
$SOFI My top 5 horses… SoFi $DGXX $TAOX $OPEN and FABC.
0 · Reply
EndGame1
EndGame1 Jun. 4 at 5:00 PM
$TAOX Finally some life. BTC crash gave us this gift. Hoping the company picked up more cheap $TAO.X
0 · Reply
JohnnyP5
JohnnyP5 Jun. 3 at 1:55 PM
$TAOX picked up 400 more shares today at $3.94. I’m hoping these will be back above $6 by the end August. 🤞
0 · Reply
SnoopyPotter
SnoopyPotter Jun. 3 at 12:54 PM
$TAOX JAy Altucher speaking at Proof of Talk at the Louvre, Paris France https://x.com/taodaily_io/status/2061838895751286958?s=20
0 · Reply
EndGame1
EndGame1 Jun. 2 at 8:21 PM
$TAOX $BTC.X is killing the sector. "Bittensor Drops 7.8% Amid Broad AI Sector Sell-Off: Bittensor's price fell 7.8% in 24 hours, dropping from $256.31 to $233.38, impacting its market cap by $190 million. Despite ongoing developments and conference presence, the broader AI token market experienced a downturn."
0 · Reply
SnoopyPotter
SnoopyPotter Jun. 2 at 7:20 PM
$TAOX The photo is from today’s (June 2, 2026) Proof of Talk by xVentures panel in Paris titled “Subnets as an Asset Class: Building the On-Ramps for Institutional Capital.” James Altucher was a key speaker with Frank Schuil (Safello), Evan Malanga (Yuma), Siam Kidd (DSV Fund), and moderator Victor Teixeira. Recent good news: As TAOX’s Digital Assets Advisor, Altucher’s high-profile appearance highlights growing institutional interest in Bittensor subnets. He also spoke at Google’s 2025 “Planet Scale Consumer AI” event on decentralized AI capturing the $300B–$30T AI boom, positioning TAOX as a major beneficiary. TAOX raised $11M (backed by Altucher and DCG) to acquire more TAO, strengthening its status as the top public pure-play DeAI vehicle.
1 · Reply
EndGame1
EndGame1 Jun. 2 at 2:10 PM
$TAOX Even though price crashed, a lot happening... "Bittensor Subnet 28 Live, TAO Becomes Gas for Private Inference Source 1 source about 1 hour Bittensor (TAO) Bridges to Solana via Wormhole Source 1 source about 2 hours Bittensor Subnet Ecosystem Accelerates with Growing Institutional Interest Source 2 sources about 2 hours Bittensor (TAO) Completes First Token Halving, Reducing Emissions Source 2 sources about 10 hours Bittensor (TAO) Gains Retail Momentum from High-Profile Crypto Accounts SourceSource 5 sources about 10 hours Bittensor (TAO) On-Chain Ownership Decentralization Strengthens"
0 · Reply
EndGame1
EndGame1 Jun. 2 at 1:57 PM
$TAOX I added another 1000 shares. Lowered my average nicely. Will be $10 by end of year. Real progress on subnets daily.
1 · Reply
TaoistTrader
TaoistTrader Jun. 2 at 10:49 AM
$TAOX sold some of my TAOX. Way too many rippers to be holding this. Will come back eventually after wash sale period over; doesn’t seem to be moving anywhere anyway. And I still hold some long regardless
2 · Reply
Linkinlogs
Linkinlogs May. 30 at 7:42 AM
$TAOX $TONX Sub $1BILLION MC's. These are going to absolutely supernova in the next crypto bullrun, or dare I say, the elusive alt season
0 · Reply
Linkinlogs
Linkinlogs May. 30 at 7:40 AM
$TAOX $TONX Whether this is a Buffet style cigar butt investment or a play into the future of finance. Sign me up
0 · Reply
EndGame1
EndGame1 May. 28 at 3:41 PM
$TAOX Sleep peacefully. Our day is coming.
1 · Reply
show_me_the_money_Adam
show_me_the_money_Adam May. 27 at 8:41 PM
$TAOX $5.50+ soon is possible.
0 · Reply
EndGame1
EndGame1 May. 26 at 5:50 PM
$TAOX They have us listed as the healthcare sector. https://www.lseg.com/content/dam/ftse-russell/en_us/documents/other/rmicro-additions-20260522.pdf
1 · Reply
drewboca
drewboca May. 26 at 2:13 PM
$TAOX where can you go to find out how much tao they own?
2 · Reply
EndGame1
EndGame1 May. 26 at 1:42 PM
$DGXX OT DiGi is my largest position. My second largest position is $TAOX Check them out. Better than BTC imo. Thye just made the Russell 2000 list Friday. Not many shares. Large funds will come in now. $SOFI $BTC
0 · Reply
EndGame1
EndGame1 May. 26 at 1:32 PM
$TAOX Congrats shareholders. TAOX will be added to the russell 2000. If this holds up, more institutions will have to add shares by the end of June. Price should be $10 right now with all of the positive bittensor news.
1 · Reply
EndGame1
EndGame1 May. 21 at 5:24 PM
$OPEN I have four stocks, all over $4 including OPEN $DGXX $TAOX and $FABC . Schwab gives zero margin buying power for any of these. They are the worst and have cost me money with these restrictions.
2 · Reply
EndGame1
EndGame1 May. 21 at 2:06 PM
$TAOX stock price hasn't reversed yet, but $TAO.X has. Seems to have bottomed $255 and now $280. Just hold and don't watch stock hourly. Will be $10/share before long.
1 · Reply
show_me_the_money_Adam
show_me_the_money_Adam May. 20 at 10:59 AM
$TAOX adding a little bit more.
0 · Reply